Cargando…
Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints
Drug discovery is a costly process which usually takes more than 10 years and billions of dollars for one successful drug to enter the market. Despite all the safety tests, drugs may still cause adverse reactions and be restricted in use or even withdrawn from the market. Drug-induced liver injury (...
Autores principales: | Liu, Xiaobin, Zheng, Danhua, Zhong, Yi, Xia, Zhaofan, Luo, Heng, Weng, Zuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254069/ https://www.ncbi.nlm.nih.gov/pubmed/32509859 http://dx.doi.org/10.1155/2020/4795140 |
Ejemplares similares
-
Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021) -
Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury
por: Dong, Huiqun, et al.
Publicado: (2022) -
Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012) -
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021) -
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
por: Moreno-Torres, Marta, et al.
Publicado: (2022)